Virchow Group   Report issue

For profit Phase 3
Founded: Hyderabad India (1983)
Status: No NME R&D (1983)

Organization Overview

First Clinical Trial
2005
NCT00500409
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Foot (Phase 3)

Foot Ulcer (Phase 3)

Hyperuricemia (Phase 3)

Osteoporosis (Phase 3)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 6